FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3288411000001107: Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26059901000001118 Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26060001000001116 Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Aminophylline hydrate 225mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is pack of Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has active ingredient Aminophylline false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has active ingredient Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has active ingredient Aminophylline hydrate false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Cetostearyl alcohol false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Aminophylline hydrate true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Phyllocontin Continus 225mg tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start